Clonidine hydrochloride NDC 52817-182

NDC codes

FDA NDC Directory

Product NDC (as listed)52817-182Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52817-0182Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
52817-182-00	52817018200	1000 TABLET in 1 BOTTLE (52817-182-00)Marketed from Jun 1, 2017
52817-182-10	52817018210	100 TABLET in 1 BOTTLE (52817-182-10)Marketed from Jun 1, 2017
52817-182-50	52817018250	500 TABLET in 1 BOTTLE (52817-182-50)Marketed from Jun 1, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clonidine hydrochloride
Generic name (nonproprietary): clonidine hydrochloride
Active ingredients: Clonidine hydrochloride — .3 mg/1
Dosage form: Tablet
Route: Oral
Labeler: TruPharma, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 070923
Marketing start: Jun 1, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha2-Agonists (Mechanism)
Identifiers: Product ID 52817-182_50b257d2-56a5-412b-e063-6394a90acae1SPL ID 50b257d2-56a5-412b-e063-6394a90acae1SPL set ID c83e4e4f-bd0e-449d-958a-dc0d570a01baRxCUI 884173, 884185, 884189, 2740803UNII W76I6XXF06UPC 0352817181107, 0352817183101, 0352817182005, 0352817182104
Pharmacologic class: Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452817018200 followed by a unit qualifier and the quantity

Package 52817-0182-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 30, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clonidine hydrochloride tablets USP are indicated in the treatment of hypertension. Clonidine hydrochloride tablets USP may be employed alone or concomitantly with other antihypertensive agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 070923

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 070923
Product	Strength	Form · route	Labeler	Product NDC
Clonidine hydrochloride	Clonidine hydrochloride .1 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-023
Clonidine hydrochloride	Clonidine hydrochloride .3 mg/1	TabletOral	Asclemed USA, Inc.	76420-286
Clonidine hydrochloride	Clonidine hydrochloride .1 mg/1	TabletOral	TruPharma, LLC	52817-180
Clonidine hydrochloride	Clonidine hydrochloride .2 mg/1	TabletOral	TruPharma, LLC	52817-181
Clonidine hydrochloride	Clonidine hydrochloride .05 mg/1	TabletOral	TruPharma, LLC	52817-183
Clonidine hydrochloride	Clonidine hydrochloride .3 mg/1	TabletOral	Bryant Ranch Prepack	71335-1624
Clonidine hydrochloride	Clonidine hydrochloride .3 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-449
Clonidine hydrochloride	Clonidine hydrochloride .3 mg/1	TabletOral	Northwind Health Company, LLC	51655-451